|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1250 GBX | -3.85% |
|
+13.64% | -41.86% |
| 07-07 | WINNERS & LOSERS: Beauty Tech ups guidance; Ixico to beat expectations | AN |
| 07-02 | WINNERS & LOSERS: Capricorn jumps after agreeing to Genel takeover | AN |
| Market Cap | 6.31M 7.22M 5.82M 5.36M 10.11M 695M 10.33M 69.55M 27.36M 340M 27.1M 26.5M 1.17B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 11.17M 12.78M 10.31M 9.5M 17.9M 1.23B 18.3M 123M 48.45M 603M 47.99M 46.94M 2.07B | EV / Sales 2026 * |
6.02x | EV / Sales 2027 * | - |
| Free-Float |
90.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Oxford BioDynamics Plc
| 1 day | -3.85% | ||
| 1 week | +13.64% | ||
| Current month | +25.00% | ||
| 1 month | -34.55% | ||
| 3 months | -41.86% | ||
| 6 months | -57.63% | ||
| Current year | -41.86% |
| 1 week | 0.09 |  | 0.14 |
| 1 month | 0.08 | | 0.18 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.75 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 60.24 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 64 | 2007-06-07 | |
Richard Compton
CEO | Chief Executive Officer | - | 2026-06-29 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 2017-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2007-06-07 | |
Paul Stockdale
BRD | Director/Board Member | - | 2017-09-14 |
David Holbrook
BRD | Director/Board Member | 65 | 2019-04-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/10/25 | Free | Chief Financial Officer | 1,500,000 | 0.0766% | ||
| 11/10/25 | Free | Founder | 15,000,000 | 0.7663% | ||
| 11/10/25 | Free | Chairman | 4,400,000 | 0.2248% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.85% | +13.64% | -76.85% | -98.93% | 7.52M | |
| -3.11% | -13.42% | +6.82% | -33.96% | 2.97B | |
| -0.06% | -9.13% | -21.62% | -83.95% | 1.82B | |
| +0.53% | +2.84% | -11.15% | -14.39% | 321M | |
| -0.42% | -2.07% | -47.10% | - | 51.17M | |
| Average | -1.38% | -0.38% | -29.98% | -57.81% | 1.03B | |
| Weighted average by Cap. | -1.78% | -10.95% | -4.97% | -50.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86M 2.12M 1.71M 1.58M 2.98M 205M 3.04M 20.47M 8.05M 100M 7.98M 7.8M 345M | - |
| Net income | - | - |
| Net Debt | 4.86M 5.56M 4.49M 4.14M 7.79M 536M 7.97M 53.63M 21.09M 262M 20.89M 20.44M 903M | - |
Employees
37
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | GBX 0.1250 | -3.85% | 47,616,638 |
| 26-07-16 | GBX 0.1300 | +23.81% | 29,704,530 |
| 26-07-15 | GBX 0.1050 | 0.00% | 19,161,803 |
| 26-07-14 | GBX 0.1050 | +5.00% | 4,842,191 |
| 26-07-13 | GBX 0.1000 | 0.00% | 17,183,646 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001250GBP
Average target price
0.0100GBP
Spread / Average Target
+700.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
